References
A.P. Shukla, S.M. Ahn, R.T. Patel, M.W. Rosenbaum, F. Rubino, Surgical treatment of type 2 diabetes: the surgeon perspective. Endocrine 40, 151–161 (2011)
C. Schmid, D.L. Goede, R.S. Hauser, M. Brandle, Increased prevalence of Body Mass Index in patients presenting with pituitary tumours: severe obesity in patients with macroprolactinoma. Swiss. Med. Wkly. 136, 254–258 (2006)
P. Álvarez-Castro, S. Sangiao-Alvarellos, I. Brandón-Sandá, F. Cordido, Endocrine function in obesity. Endocrinol. Nutr. 58, 422–432 (2011)
B. Laferrère, Do we really know why diabetes remits after gastric bypass surgery? Endocrine 40, 162–167 (2011)
S. Camastra, M. Manco, S. Frascerra, A. Iaconelli, G. Mingrone, E. Ferrannini, Daylong pituitary hormones in morbid obesity: effects of bariatric surgery. Int. J. Obes. (Lond.) 33, 166–172 (2009)
I. Kanazawa, T. Yamaguchi, T. Sugimoto, Effects of intensive glycemic control on serum levels of Insulin-like growth factor-I and dehydroepiandrosterone sulfate in type 2 diabetes mellitus. J. Endocrinol. Invest. [Epub ahead of print] 35 (5), 469–472 (2001)
F. Lanfranco, G. Motta, M.A. Minetto, E. Ghigo, M. Maccario, Growth hormone/insulin-like growth factor-I axis in obstructive sleep apnea syndrome: an update. J. Endocrinol. Invest. 33, 192–196 (2010)
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lecube, A., Vilallonga, R., Sturniolo, G. et al. Renaissance of acromegaly after bariatric surgery. Endocrine 43, 239–241 (2013). https://doi.org/10.1007/s12020-012-9759-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12020-012-9759-z